Spatial confinement of chemically engineered cancer cells using large graphene oxide sheets: a new mode of cancer

Tianshu Chen1,2, Qianqian Zhang3, Yuchen Song3

  • 1Department of Clinical Laboratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P. R. China. panqiuhui@scmc.com.cn.

Nanoscale Horizons
|September 20, 2021
PubMed

Insights

This study introduces a novel cancer therapy using large graphene oxide (LS-GO) to spatially confine cancer cells, inhibiting their migration and invasion. This approach targets unchecked cell division, a hallmark of cancer, potentially reducing side effects.

Area of Science:

  • Oncology
  • Materials Science
  • Biotechnology

Background:

  • Achieving high-efficacy cancer treatment with minimal side effects remains a significant challenge.
  • Cancer cells often share molecular similarities with normal cells, limiting the specificity of traditional therapies.
  • Existing treatments can cause off-target and on-target side effects due to the differential expression of biomarkers.

Purpose of the Study:

  • To introduce a new cancer treatment concept based on spatial confinement of cells.
  • To inhibit cancer cell migration and invasion, addressing the core issue of unchecked cell division.
  • To evaluate the efficacy of large graphene oxide (LS-GO) in this novel therapeutic approach.

Main Methods:

  • Utilizing large graphene oxide (LS-GO) to physically patch cell surfaces.
  • Implementing spatial confinement to inhibit cell migration and invasion.
  • Conducting in vitro and in vivo experiments to assess therapeutic effects.

Main Results:

  • Spatial confinement using LS-GO effectively inhibits tumor cell migration and invasion.
  • This method does not impact the viability of non-dividing cells, unlike conventional chemotherapy.
  • Demonstrated efficacy in both in vitro and in vivo models.

Conclusions:

  • Spatial confinement represents a promising new strategy for cancer treatment.
  • LS-GO mediated spatial confinement offers a potential approach to reduce treatment-related side effects.
  • This concept may be applicable as a general therapeutic for various cancer types.